New Leaf Ventures III is a Venture Capital Fund in New York with $283.05 mm assets under management. It has 34 beneficial owners. Data from SEC filing.
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry
SEC CIK
SEC advisor number
801-80793
FINRA CRD number
163897
AUM ?
$283.05 mm
Address
New Leaf Ventures III
C/O NEW LEAF VENTURE PARTNERS
7 TIMES SQUARE, SUITE 3502
NEW YORK
NY 10036
C/O NEW LEAF VENTURE PARTNERS
7 TIMES SQUARE, SUITE 3502
NEW YORK
NY 10036
Phone
646-871-6400
Ownership
Fund structure | AUM | Fund type |
---|---|---|
New Leaf Venture Partners | $745.51 mm | |
New Leaf Biopharma Opportunities I, L.P. | $34.64 mm | Venture Capital Fund |
New Leaf Biopharma Opportunities II, L.P. | $156.12 mm | Venture Capital Fund |
New Leaf Ventures I, L.P. | $7.77 mm | Venture Capital Fund |
New Leaf Ventures II, L.P. | $103.80 mm | Venture Capital Fund |
New Leaf Ventures III, L.P. | $283.05 mm | Venture Capital Fund |
New Leaf Ventures IV, L.P. | $133.80 mm | Venture Capital Fund |
NLV Co-invest II, LLC | $17.31 mm | Venture Capital Fund |
NLV Co-invest III, LLC | $9.02 mm | Venture Capital Fund |
Latest filings (excl ownership)
Latest ownership filings
4
Vijay K Lathi
11 Mar 24
SC 13G/A
Harpoon Therapeutics, Inc.
13 Feb 24
4
Vijay K Lathi
27 Oct 23
SC 13G/A
Harpoon Therapeutics, Inc.
30 Mar 23
3
Vijay K Lathi
27 Mar 23
SC 13G/A
Rallybio Corp
6 Feb 23
SC 13G/A
Harpoon Therapeutics, Inc.
6 Feb 23
SC 13G/A
Harpoon Therapeutics, Inc.
11 Feb 22
SC 13G
Rallybio Corp
11 Feb 22
SC 13D/A
Aptinyx Inc.
11 Feb 22